Dilaudid and Activated partial thromboplastin time prolonged - a phase IV clinical study of FDA data

Summary:

Activated partial thromboplastin time prolonged is reported as a side effect among people who take Dilaudid (hydromorphone hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Hypercalcaemia of malignancy.

The phase IV clinical study analyzes which people have Activated partial thromboplastin time prolonged when taking Dilaudid. It is created by eHealthMe based on reports of 95,518 people who have side effects when taking Dilaudid from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Activated partial thromboplastin time prolonged?

Activated partial thromboplastin time prolonged is found to be associated with 761 drugs and 1,209 conditions by eHealthMe. Check the latest studies of Activated partial thromboplastin time prolonged.

On Jul, 15, 2026

95,518 people reported to have side effects when taking Dilaudid.
Among them, 56 people (0.06%) have Activated partial thromboplastin time prolonged.

Could Dilaudid cause Activated partial thromboplastin time prolonged?

Among these 56 people:

How long have people been on Dilaudid when they have Activated partial thromboplastin time prolonged? *

What is the gender of people who have Activated partial thromboplastin time prolonged when taking Dilaudid? *

female: 55.36 %
male: 44.64 %

What is the age of people who have Activated partial thromboplastin time prolonged when taking Dilaudid? *

What are other drugs people take besides Dilaudid? *

What are other side effects people have besides Activated partial thromboplastin time prolonged? *

Nausea And Vomiting: 24 people, 42.86%
Nausea (feeling of having an urge to vomit): 24 people, 42.86%
High Blood Pressure: 24 people, 42.86%
Anaemia (lack of blood): 23 people, 41.07%
Pulmonary Embolism (blockage of the main artery of the lung): 21 people, 37.50%
Weakness: 20 people, 35.71%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 18 people, 32.14%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 18 people, 32.14%
Fall: 17 people, 30.36%
Haemoglobin Decreased: 17 people, 30.36%

What are the existing conditions these people have? *

Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 13 people, 23.21%
Multiple Myeloma (cancer of the plasma cells): 5 people, 8.93%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 7.14%
Stress And Anxiety: 4 people, 7.14%
Bladder Disorder: 3 people, 5.36%
Depression: 3 people, 5.36%
Hepatitis C: 3 people, 5.36%
Neuroblastoma (a cancer that forms in your nerve tissue): 3 people, 5.36%
Muscle Spasms (muscle contraction): 3 people, 5.36%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and have Activated partial thromboplastin time prolonged?

- Check whether Activated partial thromboplastin time prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dilaudid:

Dilaudid (96,466 reports)

Activated partial thromboplastin time prolonged treatments and more:

Activated partial thromboplastin time prolonged (8,799 reports)

How severe was Activated partial thromboplastin time prolonged and when was it recovered:

Activated partial thromboplastin time prolonged in Dilaudid

Expand to all the drugs that have ingredients of hydromorphone hydrochloride:

Activated partial thromboplastin time prolonged and drugs with ingredients of hydromorphone hydrochloride (103 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (761 drugs)

Browse all the conditions that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (1,209 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride (the active ingredients of Dilaudid) and Dilaudid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.